The Canadian market for veterinary vaccines, excluding Foot and Mouth disease, showed a notable decline from 2013 to 2016. This was followed by a slight recovery starting in 2017. By 2023, the market was valued at $7.69 per capita, indicating a gradual stabilization in recent years with marginal increases in value. From 2022 to 2023, the market grew by approximately 0.13%. Over the past five years, the compound annual growth rate (CAGR) was around 2.8%, suggesting a slow but steady market rebound.
Future trends to watch:
- Potential impact of technological advancements in vaccine production.
- Changes in livestock farming and pet ownership trends.
- Effect of global health initiatives on market dynamics.
- Policy shifts regarding animal health regulations and funding.
| # | 35 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Spain | 17.42 | 2023 | View data | ||
| 2 | 2 France | 14.92 | 2023 | View data | ||
| 3 | 3 Saudi Arabia | 9.73 | 2023 | View data | ||
| 4 | 4 Greece | 8.35 | 2023 | View data | ||
| 5 | 5 Portugal | 7.93 | 2023 | View data | ||
| 6 | 6 Canada | 7.69 | 2023 | |||
| 7 | 7 United Kingdom | 7.42 | 2023 | View data | ||
| 8 | 8 Costa Rica | 7.04 | 2023 | View data | ||
